Ignite Creation Date:
2024-05-06 @ 1:18 PM
Last Modification Date:
2024-10-26 @ 1:12 PM
Study NCT ID:
NCT03988114
Status:
WITHDRAWN
Last Update Posted:
2019-09-06
First Post:
2019-06-12
Brief Title:
A Study of Abemaciclib LY2835219 in Participants With HR HER2- Advanced Breast Cancer
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Metastatic Breast Cancer |
Keywords: